Cardiac Event

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Alder Therapeutics
Alder TherapeuticsSweden - Solna
1 program
CefuroximeN/A1 trial
Active Trials
NCT02850250Withdrawn0Est. Oct 2019
Zoll
ZollCA - San Jose
1 program
Upstroke Compression DefibrillationN/A1 trial
Active Trials
NCT01665755Completed180Est. Apr 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Alder TherapeuticsCefuroxime
ZollUpstroke Compression Defibrillation

Clinical Trials (2)

Total enrollment: 180 patients across 2 trials

Pharmacokinetics of Post Operative Cefuroxime in Infants Undergoing Cardiac Surgery

Start: Jul 2018Est. completion: Oct 20190
N/AWithdrawn
NCT01665755ZollUpstroke Compression Defibrillation

To Determine Optimal Time for Delivering Electrical Shocks to Cardiac Arrest Patients

Start: Jan 2016Est. completion: Apr 2019180 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space